Company news

Prothena Corporation plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Prothena Reports Second Quarter 2020 Financial Results and Provides R&D Update

August 5, 2020

Prothena Announces Phase 2 PASADENA Study Results to be Presented at International Congress of Parkinson’s Disease and Movement Disorders

August 4, 2020

Prothena to Report Second Quarter 2020 Financial Results on August 6

July 29, 2020

Prothena Reports First Quarter 2020 Financial Results and Provides R&D Update and Updated Financial Guidance

May 5, 2020

Prothena to Report First Quarter 2020 Financial Results on May 6

April 28, 2020

Prothena Provides Additional Information Regarding Upcoming Annual General Meeting of Shareholders in Response to COVID-19

April 23, 2020

Update on Phase 2 PASADENA Study of Prasinezumab (PRX002/RG7935) in Parkinson’s Disease

April 21, 2020

Prothena Announces Appointment of Brandon Smith as Chief Business Officer

March 2, 2020

Prothena Reports Fourth Quarter and Full Year 2019 Financial Results, and Provides Financial Guidance and R&D Update

February 11, 2020

Prothena to Report Fourth Quarter and Full Year 2019 Financial Results and Host Webcast Conference Call on February 12

February 4, 2020

Prothena Announces Appointment of Oleg Nodelman to its Board of Directors

December 4, 2019

Prothena Reports Third Quarter 2019 Financial Results and Provides R&D Update

November 4, 2019

Prothena to Report Third Quarter 2019 Financial Results on November 5

October 28, 2019

Prothena Reports Results from the Phase 3 VITAL Amyloidosis Study of NEOD001 (birtamimab) in AL Amyloidosis

April 17, 2019

← Newer news releases

Calls

The 5 newest of 6 calls. Every call is listed under its year.

Decks

The 5 newest of 10 decks. Every deck is listed under its year.